Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
11 studies found for:    contrave
Show Display Options
Rank Status Study
1 Not yet recruiting Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia
Conditions: Obese;   Cigarette-smoking;   Schizophrenia
Interventions: Drug: Naltrexone;   Drug: Placebo Naltrexone;   Drug: Bupropion;   Drug: Placebo Bupropion
2 Completed Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants
Condition: Heart Repolarization
Interventions: Drug: Naltrexone HCl/bupropion HCl;   Other: Placebo;   Drug: Moxifloxacin
3 Completed Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study
Condition: Methamphetamine Dependence
Interventions: Other: placebo;   Drug: Naltrexone and Bupropion SR
4 Completed Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants
Condition: Healthy Subjects
Interventions: Drug: Naltrexone/Bupropion;   Drug: Metformin
5 Completed Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers
Condition: Healthy
Interventions: Drug: Reference naltrexone 8 mg SR/bupropion 90 mg SR combination trilayer tablets (2 tablets);   Drug: Test naltrexone 8 mg SR/bupropion 90 mg SR combination trilayer tablets (2 tablets)
6 Completed Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity
Condition: Obesity
Intervention: Drug: naltrexone and bupropion SR
7 Terminated Naltrexone/Bupropion Cardiovascular Outcomes Study
Conditions: Obesity;   Cardiovascular Diseases
Interventions: Drug: Naltrexone HCl/Bupropion HCl ER;   Drug: Placebo
8 Active, not recruiting Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
Condition: Binge Eating Disorder
Interventions: Drug: Naltrexone and bupropion combination;   Other: Pill Placebo
9 Terminated Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
Conditions: Obesity;   Overweight
Interventions: Drug: NB32;   Drug: PBO;   Behavioral: Weight Management Program
10 Completed A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-Dependent
Conditions: Nicotine Dependence;   Overweight;   Obesity
Interventions: Drug: NB32;   Behavioral: Ancillary therapy
11 Completed
Has Results
Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain
Conditions: Smoking;   Nicotine Dependence
Interventions: Drug: Naltrexone;   Drug: Bupropion

Study has passed its completion date and status has not been verified in more than two years.